Your Article Summary
New Data on Four Bristol-Myers Squibb Compounds to Be Presented at AASLD 2009
Bristol Myers-Squibb Company, 10/02/09
New data on four Bristol–Myers Squibb Company compounds will be presented at the 60th annual meeting of the American Association for the Study of Liver Diseases in Boston from October to November.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas Wednesday, December 9
Repligen, 12/09/09
Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/08/09
ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
ARIAD Pharmaceuticals, 12/08/09
Article Search
Sponsor


See Latest Articles


